CSL beat expectations, guided to 5% earnings growth, and sent shares surging - but plenty of questions remain for the leaderless biotech.

There’s no real hard and fast rule on how often you should take another look at your investment strategy. Generally speaking, the whole point of a strategy is that you want to give it time to work, so ...